Why the study?
Little is known about the use of assisted reproductive technology in women with pre-existing cardiovascular disease, with no large-scale studies evaluating its impact on pregnancy outcomes.
Highlights the current knowledge gap and need for future research regarding the safety and outcomes of assisted reproductive technology in women with pre-existing cardiovascular disease.
Should not alter practice for assisted reproductive technology in women with CVD; leaves open pregnancy outcomes pending further research.
Assisted reproductive technology (ART) includes medical interventions used primarily to address infertility. With increasing accessibility to ART worldwide, more women are now able to achieve pregnancy, including those with cardiovascular disease (CVD). Unfortunately, little is known about the use of ART in women with pre-existing CVD, with no large-scale studies to date investigating the impact of ART on pregnancy outcomes in this vulnerable patient population. We discuss what is established in the literature and areas for future research to assist cardiologists in managing women with CVD seeking ART to achieve pregnancy.
No takes yet. Share an insight, caveat, or question.
Williams et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: